| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000009058 |
| Receipt No. | R000010439 |
| Official scientific title of the study | The efficacy of intra-articular hyaluronic acid injections on knee osteoarthritis patients |
| Date of disclosure of the study information | 2012/10/06 |
| Last modified on | 2017/03/30 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | The efficacy of intra-articular hyaluronic acid injections on knee osteoarthritis patients | |
| Title of the study (Brief title) | comparative trial of HA of three kinds (CHAT study) | |
| Region |
|
|
| Condition | ||
| Condition | Knee osteoarthritis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The effect of intra-articular treatment of knee osteoarthritis with hyaluronic acid in the knee joint is not based on randomized controlled trials. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | WOMAC pain, function score |
| Key secondary outcomes | 1. Visual Analog Scale
2. EQ5D 3. KOACAD parameter on plain knee radiograph |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Synvisc:
Active Comparator |
|
| Interventions/Control_2 | Suvenyl:
Active Comparator |
|
| Interventions/Control_3 | Artz:
Active Comparator |
|
| Interventions/Control_4 | Topical NSAIDs:
Active Comparator |
|
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Males and females 40 to 80 years of age.
2. The ACR Criteria for osteoarthritis of the knee. 3. Radiographic evidence of OA, Kellgren and Lawrence grade 1 to 3 on prior X-rays at screening. Only the tibio-femoral joint will be evaluated. 4. Chronic pain for at least 1 month prior to study entry (WOMAC pain score) |
|||
| Key exclusion criteria | 1. An intra-articu1ar knee injection (with any corticosteroid, hyaluronic acid preparation or other) within the previous three months.
2. A history of crystalline arthropathy or inflammatory arthritis, neutopathic arthropathy. 3. A current other problem in the affected extremity. 4. A history of clinically significant trauma or surgery. 5. Allergy or hypersensitivity to any of the study medications. 6. Joint effusion. 7. Non comp1iance to the study procedures and or non completion of the study according to investigator's judgment. |
|||
| Target sample size | 600 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroyuki Oka |
| Organization | Faculty of Medicine, the University of
Tokyo |
| Division name | 22nd Century Medical Center |
| Address | Hongo 7-3-1, Bunkyo, Tokyo |
| TEL | 03-5800-9545 |
| okah-tky@umin.ac.jp | |
| Public contact | |
| Name of contact person | Hiroyuki Oka |
| Organization | Faculty of Medicine, University of Tokyo |
| Division name | 22nd Century Medical Center |
| Address | Hongo 7-3-1, Bunkyo, Tokyo |
| TEL | 03-5800-9178 |
| Homepage URL | |
| okah-tky@umin.ac.jp | |
| Sponsor | |
| Institute | University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | TEIJIN PHARMA LIMITED. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010439 |